The global medical device industry is led by major companies such as Johnson & Johnson MedTech, Medtronic, and Siemens Healthineers, which have established strong positions across cardiovascular care, medical imaging, surgery, and patient monitoring. Other leading players, including Stryker, Abbott, Boston Scientific, and GE HealthCare, are expanding their portfolios through product innovation, acquisitions, and advanced medical technologies.
The top 10 medical device companies in 2026 are competing in an industry undergoing significant changes. Artificial intelligence (AI), robotic-assisted surgery, continuous glucose monitoring (CGM), and minimally invasive cardiovascular procedures are influencing how medical devices are developed and used.
Healthcare providers are focusing on improving treatment outcomes, reducing hospital stays, and supporting early disease detection. These priorities are creating opportunities for companies that offer advanced diagnostic, surgical, and monitoring technologies.
In addition, changing trade policies, tariffs, and supply chain requirements are encouraging manufacturers to review their production strategies. The growing use of GLP-1 medications is also influencing demand for certain diabetes management devices and related healthcare technologies.
This article examines the biggest medical device companies based on their financial performance, product portfolios, market presence, and technological developments. It also identifies the leading companies across four important segments: cardiovascular devices, diabetes care, orthopedics, and surgical robotics.
Top 10 Medical Device Companies in 2026 at a Glance
The following table compares ten major medical technology companies using their latest available FY2025 financial results. Revenue figures refer to the relevant company or medical technology business, rather than necessarily representing medical device revenue alone. Currency and fiscal-year differences should be considered when comparing international companies.
| Rank | Company | Headquarters | FY2025 revenue | Leading segment |
| 1 | Johnson & Johnson MedTech | New Brunswick, US | USD 33.79 billion | Surgery and cardiovascular |
| 2 | Medtronic | Galway, Ireland | USD 33.54 billion | Cardiovascular and neuromodulation |
| 3 | Siemens Healthineers | Forchheim, Germany | EUR 23.38 billion | Medical imaging |
| 4 | Stryker | Portage, US | USD 25.12 billion | Orthopedics |
| 5 | Abbott | Abbott Park, US | USD 21.39 billion (Medical Devices segment) | Diabetes care and cardiovascular |
| 6 | BD | Franklin Lakes, US | USD 21.84 billion | Medication delivery |
| 7 | GE HealthCare | Chicago, US | USD 20.63 billion | Medical imaging |
| 8 | Boston Scientific | Marlborough, US | USD 20.07 billion | Cardiovascular devices |
| 9 | Philips | Amsterdam, Netherlands | EUR 17.83 billion | Connected care and imaging |
| 10 | Zimmer Biomet | Warsaw, US | USD 8.23 billion | Joint reconstruction |
How We Ranked the Biggest Medical Device Companies
The companies were selected based on their global medical technology presence, financial performance, product portfolios, innovation, and importance across major medical device categories.
The financial comparison primarily uses FY2025 annual reports, SEC filings, and official company financial announcements. Where a company reports a separate MedTech or Medical Devices segment, that figure is preferred over consolidated revenue. For companies with broader healthcare portfolios, relevant segment revenue is distinguished from total company revenue.
The evaluation also considers:
Revenue and financial performance: Annual revenue, segment contribution, and reported growth.
Product portfolio: The range of devices, equipment, and medical technologies offered.
Market presence: Geographic reach and relationships with hospitals and healthcare providers.
Innovation: Investments in robotics, AI-enabled devices, imaging, and minimally invasive treatments.
2026 developments: Regulatory approvals, product launches, acquisitions, and strategic changes.
Company annual reports and regulatory disclosures provide the financial foundation. Polaris Market Research's industry analysis helps explain the competitive landscape and segment-level opportunities.
The Top 10 Medical Device Companies Ranked
Johnson & Johnson MedTech: Orthopedics, Surgery and Electrophysiology
Johnson & Johnson MedTech is one of the largest medical technology businesses in the world. Its portfolio includes surgical equipment, orthopedic implants, cardiovascular technologies, and electrophysiology products.
Headquarters and founding: New Brunswick, New Jersey, United States. Johnson & Johnson was founded in 1886.
FY2025 revenue: Its MedTech segment generated approximately USD 33.79 billion in 2025, representing 6.1% growth compared with 2024.
Flagship products and segments: Major businesses include DePuy Synthes for orthopedic solutions, Abiomed for heart recovery technologies, and Shockwave Medical for intravascular lithotripsy. Its surgical portfolio also includes advanced instruments and robotic-assisted surgery technologies.
Key 2026 move: Johnson & Johnson continues to expand its surgical technology portfolio through its OTTAVA robotic surgical system. The system is designed for multiple general surgical procedures and represents an important development in soft-tissue surgical robotics.
Why it ranks here: Its broad medical technology portfolio, global hospital relationships, and strong cardiovascular and surgical businesses support its position among the world's largest medical device companies.
Medtronic: Cardiovascular, Neuromodulation and Diabetes Leader
Medtronic is a major global medical device manufacturer with products used in cardiovascular care, neurological treatments, diabetes management, and surgical procedures. Its technologies support the treatment of chronic diseases and complex medical conditions.
Headquarters and founding: Galway, Ireland, with its operational headquarters in Minneapolis, Minnesota, United States. The company was founded in 1949.
FY2025 revenue: Medtronic reported approximately USD 33.54 billion in revenue for its fiscal year ended April 25, 2025.
Flagship products and segments: Its portfolio includes cardiac rhythm management devices, pacemakers, insulin pumps, spinal technologies, and neuromodulation systems. The Hugo robotic-assisted surgery system is another important part of its surgical technology portfolio.
Key 2026 move: Medtronic continues to expand its robotic-assisted surgery and cardiovascular technology businesses. Its Hugo system, pulsed field ablation technologies, and diabetes portfolio remain important areas of development. The company's planned separation of its diabetes business into an independent company also represents a significant portfolio change.
Why it ranks here: Medtronic's large revenue base, extensive product portfolio, global distribution network, and long-standing presence in cardiovascular and neurological care make it one of the biggest medical device companies worldwide.
Siemens Healthineers: Imaging and Diagnostics Powerhouse
Siemens Healthineers is a leading medical technology company specializing in diagnostic imaging, laboratory diagnostics, and advanced treatment technologies. Its imaging systems are widely used by hospitals and diagnostic centres.
Headquarters and founding: Forchheim, Germany. Siemens Healthineers became an independent publicly listed company in 2018, building on Siemens' long history in medical technology.
FY2025 revenue: The company reported revenue of approximately EUR 23.38 billion in fiscal 2025.
Flagship products and segments: Its portfolio includes magnetic resonance imaging (MRI), computed tomography (CT), X-ray systems, molecular imaging, laboratory diagnostics, and image-guided therapy. Its photon-counting CT technology is an important development in advanced medical imaging.
Key 2026 move: The company continues to develop AI-supported imaging solutions and photon-counting CT technology. These innovations aim to improve image quality, support clinical workflows, and help healthcare professionals make more informed diagnostic decisions.
Why it ranks here: Siemens Healthineers combines a broad imaging portfolio with diagnostic and therapeutic technologies. Its global customer base and continued investment in medical imaging innovation support its competitive position.
Stryker: Orthopedics and MedSurg Growth Engine
Stryker is a prominent medical technology company known for orthopedic implants, surgical equipment, and hospital technologies. It has a strong presence in joint replacement and robotic-assisted orthopedic procedures.
Headquarters and founding: Portage, Michigan, United States. The company was founded in 1941.
FY2025 revenue: Stryker reported net sales of approximately USD 25.12 billion in 2025, an increase of 11.2% from the previous year.
Flagship products and segments: Its major products include Mako robotic-arm-assisted surgery systems, joint replacement implants, surgical instruments, hospital beds, and emergency medical equipment.
Key 2026 move: Stryker continues to expand its robotic-assisted surgery portfolio and invest in orthopedic technologies. Its Mako platform remains central to its strategy for supporting more precise joint replacement procedures.
Why it ranks here: Its strong orthopedic portfolio, established hospital relationships, and investment in robotic-assisted surgery make Stryker an important company in the global medical device industry.
Abbott: Diabetes Care and Structural Heart
Abbott is a diversified healthcare company with a major medical devices business. It is particularly recognised for its diabetes management technologies, cardiovascular devices, and minimally invasive treatment solutions.
Headquarters and founding: Abbott Park, Illinois, United States. The company was founded in 1888.
FY2025 revenue: Abbott's Medical Devices segment generated approximately USD 21.39 billion in 2025.
Flagship products and segments: FreeStyle Libre continuous glucose monitoring systems are among its most recognised products. Other important technologies include cardiac rhythm management devices, electrophysiology systems, structural heart products, and vascular devices.
Key 2026 move: Abbott continues to expand its cardiovascular and diabetes technology portfolio. Its product developments include the Volt pulsed field ablation system and the Tendyne transcatheter mitral valve replacement system. These technologies support its expansion into minimally invasive cardiovascular treatments.
Why it ranks here: Abbott's strong diabetes care business and diversified cardiovascular portfolio make it a major competitor in the medical device industry. Its CGM business is particularly important, with global demand for continuous glucose monitoring technologies continuing to increase.
BD (Becton, Dickinson and Company): Medication Delivery and Interventional Technologies
BD is a global medical technology company focused on medication delivery, diagnostic systems, laboratory technologies, and interventional solutions. Its products are used across hospitals, laboratories, pharmaceutical manufacturing facilities, and other healthcare settings.
Headquarters and founding: Franklin Lakes, New Jersey, United States. The company was founded in 1897.
FY2025 revenue: BD reported approximately USD 21.84 billion in revenue for fiscal 2025.
Flagship products and segments: Its portfolio includes injection and infusion products, medication management systems, specimen collection devices, diagnostic instruments, and interventional medical technologies.
Key 2026 move: BD is advancing its portfolio transformation to focus on higher-growth medical technology businesses. Its strategy includes expanding biologic drug delivery, advanced patient monitoring, tissue regeneration, and other specialized technologies.
Why it ranks here: Its extensive medication delivery portfolio, established healthcare customer base, and broad international presence make BD an important participant in the medical device market.
GE HealthCare: Imaging, Ultrasound and AI
GE HealthCare is a major medical technology company specializing in medical imaging, ultrasound, patient monitoring, and pharmaceutical diagnostics. Its products help healthcare professionals diagnose and monitor various medical conditions.
Headquarters and founding: Chicago, Illinois, United States. GE HealthCare became an independent publicly traded company in 2023, following its separation from General Electric.
FY2025 revenue: GE HealthCare reported approximately USD 20.63 billion in revenue in 2025.
Flagship products and segments: Its portfolio includes MRI scanners, CT systems, ultrasound equipment, X-ray technologies, patient monitoring solutions, and contrast agents used in medical imaging.
Key 2026 move: The company continues to expand its AI-supported imaging and diagnostic portfolio. Its investments in advanced visualization and imaging technologies are aimed at improving diagnostic workflows and supporting healthcare professionals.
Why it ranks here: GE HealthCare's established position in medical imaging, broad global distribution network, and continued investment in AI-enabled technologies support its importance in the medical technology sector.
Boston Scientific: Cardiovascular Technology and Minimally Invasive Treatments
Boston Scientific is a global medical technology company specializing in minimally invasive medical devices. Its products are used in cardiovascular care, electrophysiology, endoscopy, urology, and other specialized medical procedures.
Headquarters and founding: Marlborough, Massachusetts, United States. The company was founded in 1979.
FY2025 revenue: Boston Scientific generated approximately USD 20.07 billion in net sales in 2025.
Flagship products and segments: Its portfolio includes the FARAPULSE pulsed field ablation system, WATCHMAN left atrial appendage closure devices, cardiac rhythm management technologies, and endoscopy and urology products.
Key 2026 move: Boston Scientific continues to build its electrophysiology and cardiovascular businesses. Its pulsed field ablation platform is an important part of its strategy to expand minimally invasive treatment options for patients with atrial fibrillation.
Why it ranks here: Strong financial growth, specialized cardiovascular products, and investment in minimally invasive technologies make Boston Scientific one of the important companies shaping the medical device industry.
Philips: Connected Care and Image-Guided Therapy
Philips is a global health technology company with a strong presence in diagnostic imaging, connected care, patient monitoring, and image-guided treatment. Its technologies support healthcare providers in hospitals and other clinical environments.
Headquarters and founding: Amsterdam, Netherlands. The company was founded in 1891.
FY2025 revenue: Philips reported approximately EUR 17.83 billion in group sales in 2025.
Flagship products and segments: Its portfolio includes MRI and CT scanners, ultrasound systems, patient monitoring technologies, image-guided therapy platforms, and connected healthcare solutions.
Key 2026 move: Philips announced its 2026–2028 strategic targets, focusing on profitable growth, innovation, and improved operational performance. The company is also continuing its recovery and operational improvements following the Respironics product recall.
Why it ranks here: Philips maintains a significant position in medical imaging and connected healthcare. Its combination of diagnostic equipment, patient monitoring, and clinical workflow technologies supports its global market presence.
Zimmer Biomet: Joint Reconstruction Specialist
Zimmer Biomet is a medical technology company specializing in musculoskeletal healthcare, orthopedic implants, and robotic-assisted surgical technologies. Its products support joint replacement and other orthopedic procedures.
Headquarters and founding: Warsaw, Indiana, United States. The company was formed in 2001 through the merger of Zimmer and Biomet.
FY2025 revenue: Zimmer Biomet reported approximately USD 8.23 billion in net sales in 2025.
Flagship products and segments: Its portfolio includes knee and hip replacement implants, orthopedic surgical instruments, sports medicine products, and the ROSA robotic surgical platform.
Key 2026 move: Zimmer Biomet continues to develop robotic-assisted orthopedic technologies and digital solutions for joint replacement procedures. Its ROSA platform supports surgeons during knee and hip procedures.
Why it ranks here: Its specialized focus on joint reconstruction and orthopedic technologies gives it a strong position in a major medical device category. Its robotic-assisted surgery portfolio also supports its long-term growth opportunities.
Segment Leaders: Who Leads Cardio, Diabetes, Ortho and Robotics?
The overall size of a medical technology company does not always reflect its leadership in a particular device category. Some specialized companies have developed strong positions in specific segments despite having lower overall revenue than diversified healthcare businesses.
The following comparison identifies major competitors across four important medical device categories.
| Segment | Leading companies | Other major competitors |
| Cardiovascular devices | Medtronic, Boston Scientific, Abbott | Johnson & Johnson |
| Diabetes care and CGM | Abbott, Dexcom, Medtronic | Tandem Diabetes Care |
| Orthopedics | Stryker, Zimmer Biomet | Johnson & Johnson |
| Surgical robotics | Intuitive Surgical, Medtronic, Johnson & Johnson | Stryker |
Cardiovascular Devices: Medtronic, Boston Scientific and Abbott
Cardiovascular devices represent an important category within the medical technology industry. These products support the diagnosis and treatment of heart rhythm disorders, structural heart conditions, and other cardiovascular diseases.
Medtronic has an established presence in cardiac rhythm management and cardiovascular technologies. Boston Scientific is expanding its electrophysiology portfolio through its FARAPULSE pulsed field ablation platform. Abbott is also developing advanced cardiovascular solutions, including ablation and structural heart devices.
Pulsed field ablation is gaining attention as an alternative energy-based approach for treating atrial fibrillation. Companies are investing in these technologies to expand minimally invasive treatment options.
Diabetes Care and CGM: Abbott, Dexcom and Medtronic
Continuous glucose monitoring has become an important technology for diabetes management. Unlike traditional finger-prick testing, CGM systems use sensors to measure glucose levels continuously and provide information that helps patients manage their condition.
Abbott's FreeStyle Libre portfolio and Dexcom's continuous glucose monitoring systems are major products in this category. Medtronic also offers integrated diabetes management technologies, including insulin pumps and glucose monitoring solutions.
Abbott's CGM business is particularly important within its Medical Devices segment. The increasing use of digital health tools, connected devices, and personalized diabetes management solutions is creating opportunities for manufacturers.
Orthopedics: Stryker, Zimmer Biomet and Johnson & Johnson
Orthopedic devices include joint replacement implants, bone fixation products, surgical instruments, and robotic-assisted technologies. These products are used to treat musculoskeletal conditions, injuries, and degenerative joint diseases.
Stryker has developed a strong position in orthopedic surgery through its Mako robotic-assisted surgery platform. Zimmer Biomet competes through its joint reconstruction portfolio and ROSA surgical system. Johnson & Johnson's DePuy Synthes business also offers a broad range of orthopedic solutions.
The growing demand for hip and knee replacement procedures, an ageing population, and advancements in surgical robotics are supporting innovation in this segment.
Surgical Robotics: Intuitive Surgical, Medtronic and Johnson & Johnson
Surgical robotics is transforming several areas of modern healthcare. Robotic-assisted systems provide surgeons with advanced visualization, precise instrument control, and support during complex procedures.
Intuitive Surgical is a specialist leader in this category through its da Vinci surgical systems. Medtronic competes through its Hugo robotic-assisted surgery platform, while Johnson & Johnson is developing its OTTAVA system.
Stryker also participates in robotic-assisted surgery through its Mako platform, particularly in orthopedic procedures.
The increasing adoption of minimally invasive procedures, improvements in robotic systems, and demand for precision-based surgical technologies are supporting the development of this segment.
Medical Device Industry Trends Shaping 2026
The medical device industry is evolving through technological advancements, changing healthcare needs, and supply chain developments. Several trends are influencing product innovation and competition among manufacturers in 2026.
AI-Enabled Medical Devices: Artificial intelligence is improving medical imaging, diagnostics, patient monitoring, and surgical planning. Companies are developing AI-supported technologies to improve diagnostic workflows and clinical decision-making.
Wearable Medical Devices: Continuous glucose monitors, wearable cardiac devices, and remote patient monitoring systems are gaining attention. Increasing demand for preventive healthcare and chronic disease management is supporting the adoption of connected devices. These developments are contributing to the growth of the wearable medical devices market.
Tariffs, Reshoring, and Contract Manufacturing: Changing trade policies and tariffs are encouraging manufacturers to diversify suppliers and strengthen regional production capabilities. Contract manufacturing helps companies access specialized production facilities and flexible supply chains. This is increasing the importance of the medical device contract manufacturing market.
GLP-1 Medications: Growing adoption of GLP-1 therapies is influencing diabetes care and glucose monitoring requirements. Manufacturers are focusing on connected monitoring solutions and personalized healthcare technologies. The expansion of peptide-based medicines is also creating opportunities for companies developing peptide therapeutics.
Medical Devices Market Outlook 2026–2034
The global medical devices market is expanding as healthcare systems invest in advanced diagnostic equipment, surgical technologies, patient monitoring solutions, and minimally invasive treatment options.
According to Polaris Market Research, the global medical devices market was valued at USD 584.80 billion in 2025. It is projected to reach USD 1,082.37 billion by 2034, registering a CAGR of 7.1% from 2026 to 2034.
Several factors are supporting this growth, including the increasing prevalence of chronic diseases, an ageing population, rising demand for advanced diagnostic procedures, and improvements in medical technology.
Orthopedic devices accounted for 14% of market revenue in 2025, reflecting demand for joint replacement procedures and treatments for musculoskeletal conditions.
The growing use of AI-enabled imaging, robotic-assisted surgery, and connected monitoring technologies is also creating opportunities for manufacturers.
North America held the largest regional market share in 2025, supported by advanced healthcare infrastructure, medical technology adoption, and significant healthcare spending.
Frequently Asked Questions
Who is the largest medical device company in the world?
Johnson & Johnson MedTech and Medtronic are among the largest medical device businesses, reporting USD 33.79 billion and USD 33.54 billion in FY2025 revenue, respectively.
Which medical device companies lead in surgical robotics?
Intuitive Surgical leads the segment with its da Vinci systems. Medtronic, Johnson & Johnson, and Stryker are other major competitors.
What are the biggest medtech companies in the US?
Major US-based medtech companies include Abbott, Stryker, Boston Scientific, GE HealthCare, BD, and Zimmer Biomet.
Which medical device segment is growing fastest in 2026?
Surgical robotics, continuous glucose monitoring, cardiovascular technologies, and AI-enabled imaging are important growth areas driven by technological innovation and healthcare demand.
How big is the global medical devices market?
According to Polaris Market Research, the global medical devices market was valued at USD 584.80 billion in 2025 and is projected to reach USD 1,082.37 billion by 2034, at a CAGR of 7.1%.
Conclusion
The medical device industry is being shaped by advancements in AI, robotic-assisted surgery, cardiovascular technologies, and connected patient monitoring. Companies such as Johnson & Johnson MedTech, Medtronic, Siemens Healthineers, Stryker, and Abbott continue to strengthen their positions through product innovation and portfolio expansion.
At the same time, specialized players such as Boston Scientific, Intuitive Surgical, Dexcom, and Zimmer Biomet are developing technologies for specific healthcare needs.
As healthcare providers increasingly adopt advanced medical technologies, competition among manufacturers is expected to focus on innovation, clinical outcomes, and technological capabilities.
Understanding these companies and their areas of specialization provides valuable insight into the changing medical technology landscape.
For detailed industry insights, market segmentation, competitive analysis, and future growth opportunities,Medical Devices Market from Polaris Market Research.